# Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer

> **NCT00003449** · PHASE2 · COMPLETED · sponsor: **University of Southern California** · enrollment: 35 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** dexamethasone
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00003449
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-05
- **Primary completion:** 2002-06
- **Final completion:** 2004-02
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2014-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003449, "Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*